FAQs
What are the most common long-term side effects of AML treatment?
Common long-term side effects include chronic fatigue, cardiovascular issues like high blood pressure and heart failure, endocrine disorders such as infertility and thyroid problems, secondary cancers, pulmonary complications, neurocognitive effects ("chemo brain"), chronic graft-versus-host disease (GVHD), mood and mental health issues, and musculoskeletal problems like osteoporosis.
How soon can long-term side effects appear after AML treatment?
The onset varies: fatigue may persist for 3–12 months; neurocognitive effects usually appear within 6 months to 2 years; cardiovascular and musculoskeletal problems may emerge 1–5 years later; and secondary cancers can occur 5–20 years post-treatment.
Who is at higher risk for developing long-term side effects from AML treatment?
Risk factors include age (children face more endocrine issues, adults more cardiovascular problems), treatment type (high-dose chemotherapy, anthracyclines, stem cell transplant increase risk), and genetic predisposition affecting DNA repair that can raise secondary cancer risk.
How can long-term side effects of AML be managed?
Management includes regular follow-ups with blood tests, cardiac monitoring, bone density scans, and hormone panels; lifestyle changes such as moderate exercise, balanced nutrition, good sleep hygiene, and stress reduction; and medications like hormone replacement or blood pressure control when necessary.
Is emotional support important for AML survivors dealing with long-term effects?
Yes, emotional and mental health support is vital. Counseling, cognitive behavioral therapy (CBT), and peer support groups can help manage mood disorders, stress, and anxiety related to survivorship and lingering side effects.
